{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:33:14Z","timestamp":1780356794099,"version":"3.54.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["3D Print Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Malignancies of the head and neck region, encompassing cutaneous, mucosal, and sarcomatous histologies, are complex entities to manage, comprising of coordination between surgery, radiation therapy, and systemic therapy. Malignancies of the posterior scalp are particular challenging to treat with radiation therapy, given its irregular contours and anatomy as well as the superficial location of the target volume. Bolus material is commonly used in radiation therapy to ensure that the dose to the skin and subcutaneous tissue is appropriate and adequate, accounting for the buildup effect of megavoltage photon treatment. The use of commercially available bolus material on the posterior scalp potentially creates air gaps between the bolus and posterior scalp.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentations<\/jats:title>\n                <jats:p>In this report, we created and utilized a custom 3D-printed integrated bolus and headrest for 5 patients to irradiate malignancies involving the posterior scalp, including those with cutaneous squamous cell carcinoma, melanoma, malignant peripheral nerve sheath tumor, and dermal sarcoma. Treatment setup was consistently reproducible, and patients tolerated treatment well without any unexpected adverse effects.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We found that the use of this custom 3D-printed integrated bolus\/headrest allowed for comfortable, consistent, and reproducible treatment set up while minimizing the risk of creating significant air gaps and should be considered in the radiotherapeutic management of patients with posterior scalp malignancies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41205-022-00152-w","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T03:17:38Z","timestamp":1658114258000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["3D printed integrated bolus\/headrest for radiation therapy for malignancies involving the posterior scalp and neck"],"prefix":"10.1186","volume":"8","author":[{"given":"Eric J.","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuicheng","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Godley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Sher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dat T.","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,18]]},"reference":[{"key":"152_CR1","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1016\/S0140-6736(21)01550-6","volume":"398","author":"MD Mody","year":"2021","unstructured":"Mody MD, Rocco JW, Yom SS, Haddad RI, Saba NF. Head and neck cancer. Lancet. 2021;398:2289\u201399.","journal-title":"Lancet"},{"key":"152_CR2","first-page":"311","volume":"8","author":"CF Von Essen","year":"1969","unstructured":"Von Essen CF. Radiation tolerance of the skin. Acta Radiol Ther. 1969;8:311\u201330.","journal-title":"Acta Radiol Ther"},{"key":"152_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.prro.2017.12.008","volume":"8","author":"JL Robar","year":"2018","unstructured":"Robar JL, et al. Intrapatient study comparing 3D printed bolus versus standard vinyl gel sheet bolus for postmastectomy chest wall radiation therapy. Pract Radiat Oncol. 2018;8:221\u20139.","journal-title":"Pract Radiat Oncol"},{"key":"152_CR4","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.1120\/jacmp.v16i3.5247","volume":"16","author":"S Burleson","year":"2015","unstructured":"Burleson S, Baker J, Hsia AT, Xu Z. Use of 3D printers to create a patient-specific 3D bolus for external beam therapy. J Appl Clin Med Phys. 2015;16:5247.","journal-title":"J Appl Clin Med Phys"},{"key":"152_CR5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ejmp.2020.08.010","volume":"77","author":"BA Dyer","year":"2020","unstructured":"Dyer BA, et al. Characterization and clinical validation of patient-specific three-dimensional printed tissue-equivalent bolus for radiotherapy of head and neck malignancies involving skin. Phys Med. 2020;77:138\u201345.","journal-title":"Phys Med"},{"key":"152_CR6","doi-asserted-by":"publisher","DOI":"10.2174\/1573405617666210202114336","author":"S McCallum","year":"2021","unstructured":"McCallum S, Maresse S, Fearns P. Evaluating 3D-Printed bolus compared to conventional bolus types used in external beam radiation therapy. Curr Med Imaging. 2021. https:\/\/doi.org\/10.2174\/1573405617666210202114336.","journal-title":"Curr Med Imaging"},{"key":"152_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/acm2.12552","volume":"20","author":"GC Baltz","year":"2019","unstructured":"Baltz GC, et al. Development and validation of a 3D-printed bolus cap for total scalp irradiation. J Appl Clin Med Phys. 2019;20:89.","journal-title":"J Appl Clin Med Phys"},{"key":"152_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.canrad.2015.11.003","volume":"20","author":"P Jw","year":"2016","unstructured":"Jw P, Jw Y. Three-dimensional customized bolus for intensity-modulated radiotherapy in a patient with Kimura\u2019s disease involving the auricle. Cancer Radiother. 2016;20:205\u20139.","journal-title":"Cancer Radiother"},{"key":"152_CR9","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/hed.20279","volume":"27","author":"J Bernier","year":"2005","unstructured":"Bernier J, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 2005;27:843\u201350.","journal-title":"Head Neck"},{"key":"152_CR10","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1056\/NEJMoa032641","volume":"350","author":"J Bernier","year":"2004","unstructured":"Bernier J, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350:1945\u201352.","journal-title":"N Engl J Med"},{"key":"152_CR11","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1200\/JCO.2017.77.0941","volume":"36","author":"SV Porceddu","year":"2018","unstructured":"Porceddu SV, et al. Postoperative concurrent chemoradiotherapy versus postoperative radiotherapy in high-risk cutaneous squamous cell carcinoma of the head and neck: the randomized phase III TROG 05.01 trial. J Clin Oncol. 2018;36:1275\u201383.","journal-title":"J Clin Oncol"},{"key":"152_CR12","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMoa032646","volume":"350","author":"JS Cooper","year":"2004","unstructured":"Cooper JS, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937\u201344.","journal-title":"N Engl J Med"},{"key":"152_CR13","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3389\/fonc.2014.00324","volume":"4","author":"J Kahn","year":"2014","unstructured":"Kahn J, et al. Radiation therapy in management of sporadic and neurofibromatosis Type 1-associated malignant peripheral nerve sheath tumors. Front Oncol. 2014;4:324.","journal-title":"Front Oncol"},{"key":"152_CR14","doi-asserted-by":"publisher","first-page":"e474","DOI":"10.1016\/j.ijrobp.2018.07.1357","volume":"102","author":"L Sloan","year":"2018","unstructured":"Sloan L, Terezakis SA, Blakeley JO, Slobogean B, Kleinberg LR. Long-term outcomes of Radiation Therapy (RT) in the Management of Malignant Peripheral Nerve Sheath Tumors (MPNST) in patients with Neurofibromatosis Type 1 (NF1). Int J Radiat Oncol Biol Phys. 2018;102:e474\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"152_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2045-3329-2-1","volume":"2","author":"A de BerringtonGonzalez","year":"2012","unstructured":"de BerringtonGonzalez A, Kutsenko A, Rajaraman P. Sarcoma risk after radiation exposure. Clin Sarcoma Res. 2012;2:1\u20138.","journal-title":"Clin Sarcoma Res"},{"key":"152_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S1470-2045(12)70138-9","volume":"13","author":"BH Burmeister","year":"2012","unstructured":"Burmeister BH, et al. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. Lancet Oncol. 2012;13:589\u201397.","journal-title":"Lancet Oncol"},{"key":"152_CR17","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S1470-2045(15)00187-4","volume":"16","author":"MA Henderson","year":"2015","unstructured":"Henderson MA, et al. Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02\/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial. Lancet Oncol. 2015;16:1049\u201360.","journal-title":"Lancet Oncol"},{"key":"152_CR18","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/hed.10263","volume":"25","author":"R Vongtama","year":"2003","unstructured":"Vongtama R, Safa A, Gallardo D, Calcaterra T, Juillard G. Efficacy of radiation therapy in the local control of desmoplastic malignant melanoma. Head Neck. 2003;25:423\u20138.","journal-title":"Head Neck"},{"key":"152_CR19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1445-2197.2008.04436.x","volume":"78","author":"MC Foote","year":"2008","unstructured":"Foote MC, Burmeister B, Burmeister E, Bayley G, Smithers BM. Desmoplastic melanoma: the role of radiotherapy in improving local control. ANZ J Surg. 2008;78:273\u20136.","journal-title":"ANZ J Surg"},{"key":"152_CR20","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/cncr.28415","volume":"120","author":"BA Guadagnolo","year":"2014","unstructured":"Guadagnolo BA, Prieto V, Weber R, Ross MI, Zagars GK. The role of adjuvant radiotherapy in the local management of desmoplastic melanoma. Cancer. 2014;120:1361\u20138.","journal-title":"Cancer"},{"key":"152_CR21","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1002\/cam4.783","volume":"5","author":"WG Rule","year":"2016","unstructured":"Rule WG, et al. Results of NCCTG N0275 (Alliance) - a phase II trial evaluating resection followed by adjuvant radiation therapy for patients with desmoplastic melanoma. Cancer Med. 2016;5:1890\u20136.","journal-title":"Cancer Med"},{"key":"152_CR22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/CMR.0000000000000532","volume":"29","author":"JL Abbott","year":"2019","unstructured":"Abbott JL, Qureshi MM, Truong MT, Sahni D. Comparing survival outcomes in early stage desmoplastic melanoma with or without adjuvant radiation. Melanoma Res. 2019;29:413\u20139.","journal-title":"Melanoma Res"},{"key":"152_CR23","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/0360-3016(94)90351-4","volume":"30","author":"KK Ang","year":"1994","unstructured":"Ang KK, et al. Postoperative radiotherapy for cutaneous melanoma of the head and neck region. Int J Radiat Oncol Biol Phys. 1994;30:795\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"152_CR24","doi-asserted-by":"publisher","first-page":"E649","DOI":"10.1016\/j.ijrobp.2017.06.2166","volume":"99","author":"TD Chiu","year":"2017","unstructured":"Chiu TD, et al. 3D printer-assisted Soft Silicone Compensators for Electron Modulated Radiotherapy. Int J Radiat Oncol Biol Phys. 2017;99:E649.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"152_CR25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.radonc.2016.07.011","volume":"121","author":"RA Canters","year":"2016","unstructured":"Canters RA, et al. Clinical implementation of 3D printing in the construction of patient specific bolus for electron beam radiotherapy for non-melanoma skin cancer. Radiother Oncol. 2016;121:148\u201353.","journal-title":"Radiother Oncol"},{"key":"152_CR26","doi-asserted-by":"publisher","first-page":"25660","DOI":"10.18632\/oncotarget.12829","volume":"8","author":"K Park","year":"2017","unstructured":"Park K, et al. Clinical application of 3D-printed-step-bolus in post-total-mastectomy electron conformal therapy. Oncotarget. 2017;8:25660\u20138.","journal-title":"Oncotarget"},{"key":"152_CR27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/acm2.12099","volume":"18","author":"M \u0141ukowiak","year":"2017","unstructured":"\u0141ukowiak M, et al. Utilization of a 3D printer to fabricate boluses used for electron therapy of skin lesions of the eye canthi. J Appl Clin Med Phys. 2017;18:76\u201381.","journal-title":"J Appl Clin Med Phys"},{"key":"152_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/annonc\/mdm400","volume":"19","author":"J Bernier","year":"2008","unstructured":"Bernier J, et al. Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Ann Oncol. 2008;19:142\u20139.","journal-title":"Ann Oncol"},{"key":"152_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.tipsro.2021.08.001","volume":"19","author":"SY Sin","year":"2021","unstructured":"Sin SY, et al. An evaluation of concordance between head and neck advanced practice radiation therapist and radiation oncologists in toxicity assessment for nasopharyngeal carcinoma patients. Tech Innov patient Support Radiat Oncol. 2021;19:52\u20136.","journal-title":"Tech Innov patient Support Radiat Oncol"}],"container-title":["3D Printing in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41205-022-00152-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41205-022-00152-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41205-022-00152-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T15:09:54Z","timestamp":1658156994000},"score":1,"resource":{"primary":{"URL":"https:\/\/threedmedprint.biomedcentral.com\/articles\/10.1186\/s41205-022-00152-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,18]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["152"],"URL":"https:\/\/doi.org\/10.1186\/s41205-022-00152-w","relation":{},"ISSN":["2365-6271"],"issn-type":[{"value":"2365-6271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,18]]},"assertion":[{"value":"19 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was not required for this article as it is a report on current practice.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests with the contents of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}